ArticlebioRxiv : the preprint server for biology2026
Phase diagrams for biophysical fitness landscape design.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Populations evolve toward the top of fitness landscapes in the way that physical particles experience forces toward the bottom of a potential energy landscape. We recently introduced fitness landscape design (FLD) as a means of customizing the shape of a protein's biophysical fitness landscape by using antibody sequences and concentrations as tunable control parameters. Until now, previous evidence for the feasibility of FLD has been numerical and simulated. Here, we derive an explicit analytical theory for the FLD phase diagram, providing tight bounds on the designability frontiers describing the extent to which fitnesses of different protein sequences can be tuned independently of each other. We then leverage a recently published experimental dataset of binding affinities between over 62,000 antibody variants and each of three glycoprotein antigens to construct experimental FLD phase diagrams, which show close agreement with theory. These results support the feasibility of engineering quantitatively programmable fitness landscapes for laboratory protein evolution experiments.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.